6th Circuit Rattles the Right
In the highly-partisan political and legal battle over implementation of the Affordable Care Act, the US Circuit Court of Appeals for the Sixth Circuit offered America a glimmer of reason yesterday. A three-judge panel delivered a 2-1 ruling upholding the
Citing Ohio heparin deaths, Sen. Brown has more questions for FDA on import safety
Ohio Senator Sherrod Brown says he’s disturbed that 80 percent of active pharmaceutical ingredients in U.S. drugs are foreign-made, saying that has allowed drug companies to “skirt existing regulations” and “outsource drug safety standards.”
“Drug company
States of Innovation 1
Saving Money, Saving Lives:
Maryland Paves the Way on Payment Reform
As policymakers across the country look to balance their budgets, some are turning to Medicaid, recycling the same harmful policies they’ve used year-after-year: eliminating coverage fo
Cross-Post: A Disappointing Rollback of Consumer Protections on Appeals
June 23, 2011
The Affordable Care Act (ACA) established many consumer protections, but it was only the first step. As decisions are made about implementation and regulations, the need for consumer engagement is critical. As an example of where protection
Rx Week in Review #2
Big news week: FDA laid out the problem and its plan around import safety, and Glaxo paid out $40.75 million in further settlements to states for knowingly selling adulterated or potentially-contaminated drugs. Other headlines of note:
Supremes strike do
Solving the Specialty Care Issues for Medicaid and CHIP Children
The New York Times ran an article last week on the results of a new study published in The New England Journal of Medicine (NEJM) on access to outpatient specialty care for children on Medicaid and the Children’s Health Insurance Program (CHIP). The study
TMAP and today's transparency and conduct rules
In the controversial case of the Texas Medication Algorithm Project, or TMAP, recently unsealed expert testimony in an upcoming trial in Texas reveals details of the pharma tail wagging the dog, and the need for more rigorous transparency and conflict gui
How to Get Global: FDA’s new plan
Originally tasked to inspect food and remedies made and sold in a newly-industrialized America, the FDA said today it will begin to rely on collaboration with other regulators, data-sharing and third-party auditors to safeguard the “global bazaar” of food
Navigators: Charting the Course Through the Exchange
It seems like no matter where you turned this spring, everyone was talking about health insurance Exchanges. These competitive marketplaces for health insurance are intended to provide individuals, families and small businesses with better options and inf